Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 218 entries
View as:

Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses

Phase: N/A Priority: Normal
NCT ID: NCT00722189 Org: User:
Start: 07/31/08 End: 02/28/09 Due: 02/28/10

Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02379793 Org: User:
Start: 03/31/15 End: 04/30/15 Due: 04/30/16

LEO 29102 Cream in the Treatment of Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01037881 Org: User:
Start: 12/31/09 End: 06/30/10 Due: 06/30/11

Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm

Phase: N/A Priority: Normal
NCT ID: NCT01803477 Org: User:
Start: 02/28/13 End: 12/31/13 Due: 12/31/14

LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02888236 Org: User:
Start: 09/30/16 End: 07/06/17 Due: 07/06/18

The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01768013 Org: User:
Start: 07/31/12 End: 10/31/12 Due: 10/31/13

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01130025 Org: User:
Start: 08/31/10 End: 05/31/14 Due: 05/31/15

Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04587453 Org: User:
Start: 10/27/20 End: 07/15/21 Due: 07/15/22

Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00243464 Org: User:
Start: 09/30/05 End: 05/31/06 Due: 05/31/07

Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response

Phase: N/A Priority: Normal
NCT ID: NCT03192280 Org: User:
Start: 06/19/17 End: 07/06/17 Due: 07/06/18

Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)

Phase: N/A Priority: Normal
NCT ID: NCT05194540 Org: User:
Start: 01/13/22 End: 06/21/23 Due: 06/21/24

Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT00764751 Org: User:
Start: 09/30/08 End: 01/31/09 Due: 01/31/10

A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily

Phase: N/A Priority: Normal
NCT ID: NCT00417937 Org: User:
Start: 01/31/07 End: 06/30/07 Due: 06/30/08

LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients

Phase: N/A Priority: Normal
NCT ID: NCT01167309 Org: User:
Start: 06/30/10 End: 12/31/11 Due: 12/31/12

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including Japanese

Phase: N/A Priority: Normal
NCT ID: NCT03995550 Org: User:
Start: 07/03/19 End: 07/16/20 Due: 07/16/21

PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology

Phase: N/A Priority: Normal
NCT ID: NCT01387711 Org: User:
Start: 08/31/11 End: 06/30/12 Due: 06/30/13

Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight

Phase: N/A Priority: Normal
NCT ID: NCT04306315 Org: User:
Start: 08/16/22 End: 12/16/25 Due: 12/16/26

LEO 90100 in the Treatment of Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01536938 Org: User:
Start: 05/31/12 End: 11/30/12 Due: 11/30/13

Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00216827 Org: User:
Start: 11/30/04 End: 09/30/05 Due: 09/30/06

An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A

Phase: N/A Priority: Normal
NCT ID: NCT02577185 Org: User:
Start: 11/30/15 End: 07/31/16 Due: 07/31/17

A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD

Phase: N/A Priority: Normal
NCT ID: NCT05470114 Org: User:
Start: 05/19/22 End: 10/09/23 Due: 10/09/24

A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04674826 Org: User:
Start: 02/08/21 End: 12/29/21 Due: 12/29/22

A Vasoconstriction Study With LEO 90100

Phase: N/A Priority: Normal
NCT ID: NCT01946386 Org: User:
Start: 09/30/13 End: 10/31/13 Due: 10/31/14

Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest

Phase: N/A Priority: Normal
NCT ID: NCT02361216 Org: User:
Start: 04/30/15 End: 03/31/17 Due: 03/31/18

Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children

Phase: N/A Priority: Normal
NCT ID: NCT03826901 Org: User:
Start: 02/20/19 End: 10/29/21 Due: 10/29/22